Docetaxel (DOC), a member of the taxane family of anticancer drugs, binds to tubulin and produces unnaturally stable microtubules that induce cell death. DOC is used clinically alone or in combination with other compounds to treat advanced stages of cancer. We have treated the human lung cancer cell
mRNA expression of genes altered by 5-azacytidine treatment in cancer cell lines is associated with clinicopathological parameters of human cancers
β Scribed by Y. Kanai; S. Ushijima; Y. Saito; Y. Nakanishi; M. Sakamoto; S. Hirohashi
- Publisher
- Springer-Verlag
- Year
- 2001
- Tongue
- English
- Weight
- 185 KB
- Volume
- 127
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The p53-inducible cyclin-dependent kinase inhibitor, p2 I / WAFI/CIPI (p2I), plays a pivotal role in the GI arrest or apoptosis of cells expored to genotoxic stimuli. To determine whether p2 I is a putative tumor-suppressor gene, p2 I status was investigated in 4 human bladder-cancer cell lines of k
## Abstract Head and neck cancers are treated by a combination of surgery, radiotherapy and/or chemotherapy. The clinical success of cisplatinβbased chemotherapy, mostly in combination with 5βFU or a taxane, is however limited by multifactorial intrinsic or acquired resistance. So far, known genes